Skip to main content

Farzan Filsoufi MD, Ani C. Anyanwu MD, Sacha P. Salzberg MD, Tim Frankel MD, Lawrence H. Cohn MD and David H. Adams MD

September 01, 2005 | The Annals of Thoracic Surgery

Regardless of the indication, tricuspid valve replacement (TVR) has historically been associated with high mortality and morbidity. We report the results of our experience in a high-risk patient population with an emphasis on operative mortality, long-term survival, and valve related events according to the type of prosthesis.

Page Created: January 08, 2018 Last Updated: January 08, 2018

Publications

All Publications